U.S. markets open in 4 hours 38 minutes

Biotech and Drug Stocks

Biotech and Drug Stocks

4.16k followers30 symbols Watchlist by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies.

Curated by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies. These companies develop specialty drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.

The list includes stocks priced at $5 or more with a three month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.

This watchlist is similar to a discontinued watchlist called Battling Cancer.


Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.


WatchlistChange Today1 Month Return1 Year ReturnTotal Return
Biotech and Drug Stocks-0.50%---

30 Symbols

SymbolCompany NameLast PriceChange% ChangeMarket TimeVolumeAvg Vol (3 month)Market Cap
JNJJohnson & Johnson161.98-3.24-1.96%4:00 PM EDT12.99M7.16M426.56B
RHHBYRoche Holding AG47.08-0.41-0.86%4:00 PM EDT1.61M1.41M328.85B
PFEPfizer Inc.38.81-0.67-1.70%4:02 PM EDT33.21M26.94M217.25B
NVSNovartis AG93.01-1.14-1.21%4:00 PM EDT1.31M1.89M211.06B
LLYEli Lilly and Company218.55-3.66-1.65%4:05 PM EDT3.19M3.33M209.59B
ABBVAbbVie Inc.113.12-1.78-1.55%4:03 PM EDT6.95M6.62M199.79B
MRKMerck & Co., Inc.76.61-0.62-0.80%4:02 PM EDT16.35M12.17M193.98B
NVONovo Nordisk A/S82.28-0.49-0.59%4:00 PM EDT886.93k908.32k191.19B
AZNAstraZeneca PLC58.37+0.02+0.03%4:00 PM EDT14.11M8.28M155.23B
BMYBristol-Myers Squibb Company66.47-0.30-0.45%4:00 PM EDT15.04M10.46M148.42B
AMGNAmgen Inc.238.68-2.08-0.86%4:00 PM EDT5.56M2.64M137.13B
SNYSanofi52.86-0.38-0.71%4:00 PM EDT5.68M1.32M133.96B
GSKGlaxoSmithKline plc39.84-0.73-1.80%4:00 PM EDT9.92M4.64M100.23B
ZTSZoetis Inc.185.39-1.05-0.56%4:06 PM EDT2.96M1.78M88.02B
GILDGilead Sciences, Inc.66.61-0.61-0.91%4:00 PM EDT11.46M7.18M83.54B
MRNAModerna, Inc.199.19-3.28-1.62%4:00 PM EDT6.66M9.32M79.98B
BAYRYBayer Aktiengesellschaft15.73-0.24-1.47%3:59 PM EDT217.57k387.16k62.14B
BIIBBiogen Inc.388.44+4.92+1.28%4:00 PM EDT2.87M1.75M58.48B
REGNRegeneron Pharmaceuticals, Inc.537.92+1.91+0.36%4:00 PM EDT914.79k815.33k57.31B
TAKTakeda Pharmaceutical Company Limited16.55-0.36-2.13%4:00 PM EDT4.43M2.42M52.79B
BNTXBioNTech SE212.42-1.78-0.83%4:00 PM EDT2.26M3.04M51.30B
VRTXVertex Pharmaceuticals Incorporated187.85-0.51-0.27%4:00 PM EDT3.52M1.98M48.63B
ALXNAlexion Pharmaceuticals, Inc.180.69+0.72+0.40%4:00 PM EDT3.91M2.07M40.06B
SGENSeagen Inc.156.31+2.93+1.91%4:00 PM EDT1.14M894.35k28.37B
GMABGenmab A/S42.92-0.61-1.40%4:00 PM EDT6.15M527.94k28.05B
RPRXRoyalty Pharma plc44.02-0.11-0.25%4:00 PM EDT7.11M1.95M26.73B
HZNPHorizon Therapeutics Public Limited Company94.61+2.47+2.68%4:00 PM EDT6.86M1.65M21.27B
ALNYAlnylam Pharmaceuticals, Inc.176.89+4.64+2.69%4:00 PM EDT1.52M528.49k20.79B
CTLTCatalent, Inc.108.61-1.95-1.76%4:03 PM EDT1.15M1.00M18.50B
INCYIncyte Corporation83.96+0.83+1.00%4:00 PM EDT2.07M1.21M18.46B
  • Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The International Liver Congress™ 2021
    Business Wire

    Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The International Liver Congress™ 2021

    FOSTER CITY, Calif., Jun 21, 2021--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that more than 70 abstracts from the company’s liver disease programs will be presented at The International Liver Congress™ 2021 (ILC) taking place from June 23-26. The breadth of data reflects Gilead’s continued commitment to liver disease, including the recent expansion into chronic hepatitis delta virus (HDV), with Hepcludex® (bulevertide) as the first-in-class treatment for people with HDV conditionally

  • Transactions in connection with share buy-back program

    Transactions in connection with share buy-back program

    Company Announcement COPENHAGEN, Denmark; June 21, 2021 – Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares. The following transactions were executed under the program from June 14, 2021, to June 18, 2021: No.

  • SoftBank, Nomura Tapped to Offer Moderna Shots for Employees

    SoftBank, Nomura Tapped to Offer Moderna Shots for Employees

    (Bloomberg) -- In a country where workplaces play an outsized role in people’s lives, Japan is betting that enlisting its largest corporations to roll out Covid-19 vaccines will add fuel to a much-scrutinized inoculation drive.Still grappling with a rollout that’s deployed only enough doses to cover 11% of the population, the Japanese government is allowing its biggest corporate brand names and employers like Toyota Motor Corp., SoftBank Group Corp., and Nomura Holdings Inc. to administer shots